All-at-Once Spatial Proteome Profiling with PSPro: Advances in Single-Cell-Type Resolution

Study Background and Research Question

Understanding the spatial organization of proteins within tissues is fundamental to decoding the cellular interactions and molecular mechanisms driving physiological and pathological processes. Traditional spatial proteomics methods, such as laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging, have yielded significant insights into tissue biology. However, these approaches often involve trade-offs between spatial resolution, proteome coverage, and throughput, limiting their utility in profiling complex tissue environments at the single-cell-type level. The study by Mao et al. addresses a critical question: can a single workflow comprehensively map proteomes of diverse cell types within intact tissue slices, preserving spatial context and achieving single-cell-type selectivity (Mao et al., 2025)?

Key Innovation from the Reference Study

The principal innovation presented by Mao et al. is the development of PSPro (Proximity Labeling for Spatial Proteomics), an antibody-targeted proximity labeling method that enables high-coverage, selective proteome capture from single tissue slices at sub-micrometer resolution. This approach transforms conventional antibody-epitope visualization into a high-throughput paradigm, capturing the entire proteome of specific cell types rather than only a few markers. By optimizing labeling parameters and leveraging efficient affinity purification, PSPro achieves comprehensive and spatially resolved proteomic profiling in a single, scalable workflow.

Methods and Experimental Design Insights

PSPro integrates several methodological advances to overcome the limitations of existing spatial proteomics strategies. The core workflow consists of:

• Antibody-Targeted Proximity Labeling: Primary antibodies specific to cell-type markers are used to direct a proximity labeling reaction, biotinylating proteins in the immediate vicinity of the epitope. This ensures cell-type specificity and spatial precision.
• Optimized Labeling Parameters: The study systematically varies labeling conditions to maximize selectivity and coverage, minimizing off-target effects and sample loss.
• Efficient Affinity Purification: Biotinylated proteins are enriched using streptavidin-based affinity capture, enabling subsequent mass spectrometry analysis of thousands of proteins per cell type.
• Integration with Laser Microdissection (LMD): For enhanced spatial resolution, LMD is employed to isolate specific regions or cell subpopulations within tissue slices, enabling direct comparison of distinct cell types and spatial heterogeneity within the same tissue section.

This workflow is benchmarked against established proteomic approaches, including flow cytometry-based and conventional LMD-MS workflows, to ensure accuracy and reproducibility (Mao et al., 2025).

Protocol Parameters

• Antibody incubation: Use well-validated, cell-type-specific primary antibodies; optimize concentration to balance coverage and specificity.
• Proximity labeling: Biotinylation reaction time and reagent concentration must be empirically adjusted for each tissue type to maximize labeling efficiency while minimizing background.
• Affinity purification: Employ high-capacity streptavidin beads and stringent washing steps to reduce non-specific binding and increase proteome depth.
• Optional LMD step: For region-specific analysis, perform LMD prior to affinity purification to isolate microanatomical regions of interest.
• Mass spectrometry analysis: Use high-sensitivity, high-resolution MS instrumentation for optimal protein identification and quantification.

Core Findings and Why They Matter

Applying PSPro to pancreatic tumor and spleen tissue slices, Mao et al. profiled the proteomes of ten distinct cell types in a single experiment. The method enabled enrichment and analysis of thousands of proteins per cell type, including established markers and functional regulators. Notably, integration with LMD revealed spatial heterogeneity among cancer and immune cell subsets within the same tissue slice, illustrating the technique's power to resolve microenvironmental complexity at single-cell-type resolution (Mao et al., 2025).

These findings advance the capacity to interrogate spatial proteomic landscapes without sacrificing throughput or coverage. The approach is particularly impactful for research on tumor microenvironments, immune cell infiltration, and tissue-specific regulatory mechanisms, providing a scalable platform for both discovery and translational studies.

Comparison with Existing Internal Articles

Several internal resources discuss tools and strategies for signal amplification in immunohistochemistry and related applications. For example, one analysis details how the Cy3 TSA Fluorescence System Kit enables sensitive detection of low-abundance biomolecules via tyramide signal amplification, a principle conceptually related to the affinity labeling step in PSPro. Another resource (Elevating Signal Amplification) highlights the importance of robust fluorescence amplification for visualizing elusive targets in tissue sections, echoing the need for high sensitivity and specificity in spatial proteomics.

However, PSPro distinguishes itself by shifting from marker visualization to comprehensive proteome capture, leveraging proximity-based biotinylation and mass spectrometry rather than traditional fluorescence-based readouts. While fluorescence amplification kits such as the Cy3 TSA Fluorescence System Kit are invaluable for targeted biomolecule detection and imaging, PSPro enables a systems-level view, mapping proteomic diversity within tissue microenvironments. The shared emphasis on signal amplification and spatial precision underscores a continuum of technological solutions for molecular tissue analysis, each tailored to distinct research objectives.

Limitations and Transferability

Despite its strengths, PSPro has limitations. The method’s reliance on high-quality, cell-type-specific antibodies may restrict its use to well-characterized markers, and the proximity labeling chemistry, while selective, may still label neighboring proteins beyond the strict cell-type boundary. Additionally, the requirement for advanced mass spectrometry infrastructure and the complexity of affinity purification workflows may limit accessibility for some laboratories. Transferability to other tissue types or disease models will depend on the optimization of labeling protocols and antibody panels for each context.

Research Support Resources

Researchers aiming to implement spatial proteome profiling or enhance detection sensitivity in tissue-based assays can leverage advanced signal amplification methods. For targeted studies—such as highly sensitive immunohistochemistry, immunocytochemistry, or in situ hybridization—the Cy3 TSA Fluorescence System Kit (SKU K1051) provides robust tyramide-based fluorescence amplification compatible with standard microscopy. This kit enables reliable detection of low-abundance proteins and nucleic acids, supporting workflows where high signal-to-noise is critical, as detailed in recent lab-oriented articles. While PSPro and fluorescence-based TSA kits serve different analytic goals, both exemplify the growing toolkit for dissecting spatial information in complex tissues and advancing molecular pathology research.